DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Miners JO, Chau N, Rowland A. et al.
Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: implications for hyperbilirubinemia.
Biochem Pharmacol 2017;
129: 85-95
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.